Sumatriptan Injection
Product Images NDC 36000-289

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 36000-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-label (Image 01)

Label for Sumatriptan Injection, USP 6 mg/0.5 mL, a subcutaneous injection supplied as a 0.5 mL single-dose vial. Manufactured for Baxter Healthcare Corporation, Deerfield, IL. The label includes NDC 36000-289-01, bar code, manufacturing lot number, and expiration date space. Made in India.*

FDA Label Image

Carton-label-01 (Image 02)

Box label for Sumatriptan Injection, USP 6 mg/0.5 mL by Baxter Healthcare Corporation. The label states the product is for subcutaneous injection and contains 5 single-dose vials of 0.5 mL each. Manufactured by Baxter Pharmaceuticals India Private Ltd. The label includes barcode, batch number, and expiration date areas.*

FDA Label Image

Carton-label-02 (Image 03)

Packaging label for Sumatriptan Injection, USP 6 mg/0.5 mL by Baxter Healthcare Corporation. The box contains 10 single-dose vials of 0.5 mL each for subcutaneous injection. Manufactured by Baxter Pharmaceuticals India Private Ltd. The label includes the NDC 36000-289-10 and dosing information.*

FDA Label Image

Carton-label-03 (Image 04)

Label artwork for Sumatriptan Injection, USP 6 mg/0.5 mL subcutaneous injection by Baxter Healthcare Corporation. The label is for a pack of 25 single-dose 0.5 mL vials. The label includes product name, strength, dosage form, route, NDC 36000-289-25, manufacturer information, barcode, and batch details area.*

FDA Label Image

Structural Formula (Sum05 0000 01)

Chemical structure diagram of sumatriptan, showing its molecular components and spatial arrangement, including its sulfonamide and indole groups, as well as the associated molecule of tartaric acid.*

FDA Label Image

Figure 1 (Sum05 0000 02)

A line graph showing the estimated percentage of patients with relief over time (minutes) comparing Sumatriptan injection 6 mg/0.5 mL to placebo. The x-axis represents time from 0 to 25 minutes, and the y-axis shows the percentage of patients with relief from 0% to 100%. Two lines show higher relief rates for Sumatriptan compared to placebo over the measured time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.